| abstract |
The present invention relates to the discovery that VEGF, P1GF, and sFlt-1 levels are increased in inflammatory response such as in sepsis, severe sepsis, or septic shock. Additionally, the invention provides methods of identifying treatments as well as providing treatments for such an inflammatory response, which include decreasing VEGF or P1GF levels, or increasing sFlt-1 or P1GF levels. |